The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Antibody fragments as nanoparticle targeting ligands: a step in the right direction
Open accessAbstract
Recent advances in nanomedicine have shown that dramatic improvements in nanoparticle therapeutics and diagnostics can be achieved through the use of disease specific targeting ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Localized Surface Plasmon Resonance Spectroscopy and Sensing
Willets, K. A., & Van Duyne, R. P. (2007) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.58.032806.104607 · Cited by 6,171
Carbon Nanotubes: Present and Future Commercial Applications
De Volder, M. F. L., Tawfick, S. H., Baughman, R. H., & Hart, A. J. (2013) · Science · doi:10.1126/science.1222453 · Cited by 5,587
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
Wei, H., & Wang, E. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35486e · Cited by 3,779
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Surface-Enhanced Raman Spectroscopy
Stiles, P. L., Dieringer, J. A., Shah, N. C., & Van Duyne, R. P. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.112814 · Cited by 3,178
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
SLOWING, I., VIVEROESCOTO, J., WU, C., & LIN, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.012 · Cited by 2,653
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
Cited by
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
Metal–phenolic network composites: from fundamentals to applications
Lin, Z., Liu, H., Richardson, J. J., Xu, W., Chen, J., Zhou, J., & Caruso, F. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00273j · Cited by 283
Tiwari, P., Yadav, K., Shukla, R. P., Gautam, S., Marwaha, D., Sharma, M., & Mishra, P. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.016 · Cited by 88
Monoclonal Antibodies: A Prospective and Retrospective View
Sivaccumar, J., Sandomenico, A., Vitagliano, L., & Ruvo, M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200219142231 · Cited by 14
Metadata
- Authors
- Richards, D. A., Maruani, A., & Chudasama, V.
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 8
- Issue
- 1
- Pages
- 63-77
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- OpenAlex
- W2520629744
- Cited by
- 294
- References
- 133
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibody fragments as nanoparticle targeting ligands: a step in the right direction. https://app.cochat.ai/papers/10.1039/c6sc02403c
- The paper
- Richards, D. A., Maruani, A., & Chudasama, V. (2017). Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chemical Science. https://doi.org/10.1039/c6sc02403c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
